Literature DB >> 21795019

Factors determining outcomes of aortic valve surgery in patients with aortic regurgitation due to Behçet's disease: impact of preoperative echocardiographic features.

Jae-Kwan Song1, Mi-Jeong Kim, Dae-Hee Kim, Jong-Min Song, Duk-Hyun Kang, Inchul Lee, Seung Keun Lee, Bin Yoo.   

Abstract

BACKGROUND: Paravalvular leakage after open heart surgery is notoriously common in patients with aortic regurgitation (AR) due to Behçet's disease. The aim of this study was to test whether initial echocardiographic findings are useful to predict recurrent AR.
METHODS: Lesion severity on preoperative echocardiography was scored for redundant aortic valve cusp (0-2 points), aortic pseudoaneurysm (0-2 points), and dissection of the adjacent interventricular septum (0-2 points) in 22 patients with severe AR due to Behçet's disease (13 men; mean age, 42.4 ± 11.5 years), which was confirmed by histologic examination after open heart surgery.
RESULTS: Recurrent AR developed in 13 patients at a median of 12.6 months (range, 2.4-70.3 months) after the first operation, and 10, four, and one patient underwent second, third, and fourth surgery, respectively, to control recurrent AR; three patients died. Those patients with recurrent AR had a significantly higher incidence of repeat surgery or death (84.6% [11 of 13] vs 0%, P = .015). Multivariate analysis showed that perioperative immunotherapy (hazard ratio, 0.002; 95% confidence interval, 0.001-0.1761; P = .006) and total echocardiographic score (hazard ratio, 2.843; 95% confidence interval, 1.350-5.991; P = .006) were independent factors associated with recurrent AR. The 1-year, 3-year, and 5-year AR-free survival rates were 73 ± 10%, 46 ± 12%, and 39 ± 12%. The optimal cutoff value for total echocardiographic score was 3.0, and the 5-year AR-free survival rates were significantly lower in patients with scores ≥ 3 (20 ± 13% vs 50 ± 19%, P = .022).
CONCLUSIONS: This retrospective study confirms that initial echocardiographic features can provide useful prognostic information in patients with AR due to Behçet's disease.
Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21795019     DOI: 10.1016/j.echo.2011.06.006

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  4 in total

1.  Predictors of paravalvular aortic regurgitation after surgery for Behcet's disease-related severe aortic regurgitation.

Authors:  Hong-Mi Choi; Hyung-Kwan Kim; Sung-Ji Park; Hyun-Jung Lee; Yeonyee E Yoon; Jun-Bean Park; Yong-Jin Kim; Goo-Young Cho; In-Chang Hwang; Dae-Won Sohn; Jae K Oh
Journal:  Orphanet J Rare Dis       Date:  2019-06-10       Impact factor: 4.123

Review 2.  Multimodality Evaluation of Aortic Insufficiency and Aortitis in Rheumatologic Diseases.

Authors:  Eunjung Choi; Lena M Mathews; Julie Paik; Mary C Corretti; Katherine C Wu; Erin D Michos; Allison G Hays; Monica Mukherjee
Journal:  Front Cardiovasc Med       Date:  2022-04-12

3.  Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center.

Authors:  Luxi Sun; Jinjing Liu; Xiufeng Jin; Zhimian Wang; Lu Li; Wei Bai; Yunjiao Yang; Chanyuan Wu; Wei Chen; Shangdong Xu; Jun Zheng; Wenjie Zheng
Journal:  Ther Adv Chronic Dis       Date:  2021-06-22       Impact factor: 5.091

4.  Prognostic analysis of Behçet's disease with aortic regurgitation or involvement.

Authors:  X Li; X Wen; J Xu; Q Lin; L Liu
Journal:  Neth Heart J       Date:  2021-04-20       Impact factor: 2.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.